Portfolio of 40+ products
Various
DevelopmentActive
Key Facts
About Praxgen Pharmaceuticals
Praxgen Pharmaceuticals, founded in 2016 and headquartered in San Diego with key operations in New Jersey, is a private, commercial-stage generic drug developer. The company has a strategic focus on complex generics, with over 40 products in development and a track record of ANDA approvals and product launches, such as generic Medrol and Fosaprepitant. Leveraging a hybrid model of in-house R&D and external manufacturing partnerships, Praxgen aims to capture value in high-barrier, high-market-size generic drug segments while navigating the competitive and regulatory pressures inherent to the industry.
View full company profileTherapeutic Areas
Other Various Drugs
| Drug | Company | Phase |
|---|---|---|
| New Generic Approvals | China SXT Pharmaceuticals | Application Submitted / BE Stage |
| New Dosage Form Development | Universe Pharmaceuticals | Development |
| New TCM Formula Registration | Universe Pharmaceuticals | Development |
| CBD/THC Oil Formulation | Avecho Biotechnology | Preclinical |
| Bag APIs | ChemWerth | Approved |
| Oral APIs | ChemWerth | Approved |
| Companion Diagnostics Development | Kiffik Biomedical | Pre-clinical |
| Portfolio of Complex Generics & 505(b)(2) Products | Alvogen | Approved/Commercial |
| Drug Repositioning Service | Biovista | Service |
| Custom Control Development | Anchor Molecular | Development/Commercial |
| Portfolio from Steriscience Partnership | Armas Pharmaceuticals | ANDA Development/Filing |
| Generic Medicinal Products Development | Basic Pharma | Commercial |